InvestorsHub Logo
Followers 30
Posts 3998
Boards Moderated 0
Alias Born 07/25/2007

Re: ronpopeil post# 695

Friday, 03/23/2018 1:08:22 AM

Friday, March 23, 2018 1:08:22 AM

Post# of 796
PGNX is one frustrating stock. No approval is ever guaranteed, and this 3 month delay is due to new manufacturing data provided by PGNX to the FDA. . Obviously I am disappointed by the delay but it is not a disaster, well at least yet. It is better that the issue isn't the data but there won't be approval without FDA blessing of the manufacturing process. The delay means the next quarterly report about Relistor sales data will likely come before the FDA decision, and I am hopeful we will see continued sales growth.

https://progenicsgc.gcs-web.com/news-releases/news-release-details/progenics-pharmaceuticals-announces-three-month-extension-pdufa